Vaccination

GSK and IQVIA launch Vaccine Track, a data trend platform to help improve adult vaccination in communities nationwide

Retrieved on: 
Monday, August 8, 2022
Technology, Infectious Diseases, Professional Services, Software, Biotechnology, General Health, Data Analytics, Pharmaceutical, Health, Data Management, Death, Multimedia, Ageing, Medicine, Public health, IQV, Industry, NYSE, Technology, SVP, GSK, Research, Annual report, Government, Patient, CDC, COVID-19, Company, Vaccine, Partnership, Awareness, Immunization, Vaccination, Amyris (company), Degenerative disease, Privacy, Solution, MD, Pharmacy, Public policy, Adult, Disease, Pharmaceutical industry, IQVIA, Technology, Infectious Diseases, Professional Services, Software, Biotechnology, General Health, Data Analytics, Pharmaceutical, Health, Data Management

This resource will provide frequent and relevant data on trends to focus and enhance public health efforts.

Key Points: 
  • This resource will provide frequent and relevant data on trends to focus and enhance public health efforts.
  • Vaccination rates for CDC-recommended vaccines were low before the pandemic and despite heightened awareness, adult immunization rates significantly declined during the pandemic, compounding already low rates.
  • Vaccine Track data insights revealed sustained decline of recommended adult immunizations, excluding flu vaccinations, across the US during the pandemic.
  • Vaccine Track is a comprehensive platform provided by GSK, in partnership with IQVIA, for use by public health officials, industry leaders and medical professionals to strengthen vaccination data transparency, raise awareness and publicly share vaccination trends.

Sermo Barometer Reveals Growing Concern Among Global Physicians Regarding Monkeypox

Retrieved on: 
Monday, August 8, 2022
Women, Pharmaceutical, Men, General Health, Health, Infectious Diseases, Consumer, LGBTQ+, Monkeypox, World Health Organization, Intelligence, Collaboration, Syphilis, Frazier Healthcare Partners, Research institute, HPV, FAC, Human, Research Institute for Tropical Medicine, Patient, COVID-19, Education, View, Vaccine, Water, Vaccination, MPH, WHO, World, HCP, Physician, Pharmaceutical industry, MD

Based on lessons from the COVID-19 pandemic, 36% feel public health authorities should prioritize public education combating misinformation/disinformation to prepare for a potential monkeypox pandemic.

Key Points: 
  • Based on lessons from the COVID-19 pandemic, 36% feel public health authorities should prioritize public education combating misinformation/disinformation to prepare for a potential monkeypox pandemic.
  • For patients infected by monkeypox who want to prevent spreading to others, physicians agree (80%) to isolate at home until rashes are completely healed.
  • This survey was the 25th edition of Sermos ongoing Barometer that amplifies the voice of physicians globally on key topics, including COVID-19, specialty-specific patient care, and most recently monkeypox.
  • Sermo turns physician experience, expertise, and observations into actionable insights for the global healthcare community.

CHCI TO HONOR MUSIC LEGEND CELIA CRUZ AND SECRETARY XAVIER BECERRA AT THE 45TH ANNUAL AWARDS GALA

Retrieved on: 
Monday, August 8, 2022
Interview, 50,000,000 Elvis Fans Can't Be Wrong: Elvis' Gold Records, Volume 2, Map, Washington Convention Center, House, Capital Arts Entertainment, Patient safety, Music, Medal, Walter, Medicare, Louisiana House of Representatives, CEO, Sport, Leadership, United States Department of Health and Human Services, Congress, Nextgen, History, Department, Human services, American Dream, Institute, CHCI, COVID-19, Grammy Awards, Nebraska Department of Health & Human Services, Medicaid, Walter E. Washington Convention Center, Eye, Parent, Vaccination, ACA, Culture, Brain, Congressional Hispanic Caucus, HHS, Lo Nuestro Excellence Award, Representative, The arts, Magic, Student, Civil and political rights, Public relations, Management, Entertainment, Pharmaceutical industry, Science, Medicine, Health, Education

"We are proud to celebrate and recognize these two trailblazers at our 45th Annual Awards Gala this year."

Key Points: 
  • "We are proud to celebrate and recognize these two trailblazers at our 45th Annual Awards Gala this year."
  • "We are thrilled to honor both Celia Cruz and Secretary Xavier Becerra at this year's gala.
  • Throughout her career, Celia Cruz redefined salsa, recording more than 80 albums and songs, earning 23 Gold Records, and winning five Grammy Awards.
  • Now, as part of Cruz's amazing musical legacy, The Celia Cruz Foundation raises funds for Hispanic students whose dream is to study music.

OCEANIA CRUISES INTRODUCES SAFE, SIMPLE TRAVEL REQUIREMENTS

Retrieved on: 
Monday, August 8, 2022
Norwegian Cruise Line Holdings, Multimedia, Ageing, Panama, Travel, Industry, CEO, NYSE, Regent Seven Seas Cruises, Policy, Relaxation, Review, Company, Vaccine, NCLH, Vaccination, COVID-19 testing, Bermuda, COVID-19, Panama Canal, UN, PCR, Cruise line, Health, Revolution, Tourism

MIAMI, Aug. 8, 2022 /PRNewswire/ -- Oceania Cruises, the world's leading culinary- and destination-focused cruise line, has revised its SailSafe Health and Safety protocols to be simpler, easier, and offer all travelers an open door to explore the world.

Key Points: 
  • The world has been re-opening quickly and once more, we are pleased to welcome all travelers, of all ages, to safely explore the world with comfort and ease aboard the small, luxurious ships of Oceania Cruises," stated Howard Sherman, President and CEO of Oceania Cruises.
  • While vaccination and testing requirements have been relaxed, Oceania Cruises continues to strongly recommend all guests to be up to date with their vaccines and to test at their convenience prior to travel.
  • For additional information on Oceania Cruises' small-ship luxury product, exquisitely crafted cuisine, and expertly curated travel experiences, visit OceaniaCruises.com, call 855-OCEANIA, or speak with a professional travel advisor.
  • With headquarters in Miami, Oceania Cruises is owned by Norwegian Cruise Line Holdings Ltd., a diversified cruise operator of leading global cruise brands which include Norwegian Cruise Line, Oceania Cruises and Regent Seven Seas Cruises.

Intranasal Drug Delivery Global Market Report 2022: Rise in Prevalence of COPD Drives Opportunities - ResearchAndMarkets.com

Retrieved on: 
Monday, August 8, 2022
Health, Pharmaceutical, Pain management, Depression, Anesthetic, Asthma, Sexual dysfunction, Analgesic, Growth, Prevalence, Patient, Degenerative disease, COVID-19, Nasal cavity, Nasal administration, Gel, COPD, Joint Medical Service (Germany), CAGR, Vaccination, Anxiety, Calcium, Powder, Osteoporosis, Adoption, Pharmaceutical industry, Pet

The "Intranasal Drug Delivery - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Intranasal Drug Delivery - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Nasal drug delivery route is suitable for systematic drug delivery, needleless vaccination, and for drug candidates with low oral absorption or vulnerable to first-pass effect in the human body.
  • This segment currently accounts for a 31.5% share of the global Intranasal Drug Delivery market.
  • North America represents the leading global market for intranasal drug delivery, driven by the growing prevalence of respiratory disorders, such as asthma and COPD; the high adoption of drug delivery technique in healthcare institutions; and the growing affinity of patients for affordable generic drugs.

Norwegian Cruise Line Holdings Announces Revisions to Vaccination and Testing Protocols

Retrieved on: 
Monday, August 8, 2022
Epidemic, Norwegian Cruise Line Holdings, U.S. Securities and Exchange Commission, Compte rendu, Norwegian Cruise Line, Ageing, Travel, Industry, Name, NYSE, Legislation, GLOBE, Regent Seven Seas Cruises, Forward-looking statement, Failure, Private Securities Litigation Reform Act, Growth, Policy, Investment, Security (finance), Annual report, Environment, Relaxation, Unemployment, Compliance, Piracy, Income, Health, Public expenditure, Stock dilution, COVID-19, Company, Program, NCLH, Safety, Pandemic, Vaccination, Maintenance, Bermuda, Goal, Insurance, Cruise line, Friction, Information technology, Revolution, Tourism, Risk management

MIAMI, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (the Company) today announced revisions to its SailSAFE health and safety protocols which further align the Company to the broader travel, leisure and hospitality industry worldwide.

Key Points: 
  • MIAMI, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (the Company) today announced revisions to its SailSAFE health and safety protocols which further align the Company to the broader travel, leisure and hospitality industry worldwide.
  • This policy will go into effect across Norwegian Cruise Line, Oceania Cruises and Regent Seven Seas Cruises for all sailings that commence on or after September 3, 2022.
  • The Company continues to strongly recommend all guests be up to date on vaccination protocols and test at their convenience prior to travel.
  • Unvaccinated guests, aged 12 and older, or those who cannot or decline to provide proof of vaccination, will need to present a negativemedically administeredPCR or Antigen COVID-19 test taken no more than 72 hours prior to boarding
    About Norwegian Cruise Line Holdings Ltd.
    Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) is a leading global cruise company which operates the Norwegian Cruise Line, Oceania Cruises and Regent Seven Seas Cruises brands.

Global Impact launches new $5M research fund - Vaccine Confidence Fund II to further understand how Social Media may be leveraged to Increase Vaccination Confidence and Uptake

Retrieved on: 
Friday, August 5, 2022
Online, MSD, Request for proposal, Public health, World Health Organization, Sabin Vaccine Institute, United Kingdom, Digital, GLOBE, Technology, World Bank, Digital economy, NJ, Research, Meta, Global Impact, Vaccine Confidence Project, Merck, World, Centre for History in Public Health, London School of Hygiene and Tropical Medicine, COVID-19, Social media, Vaccine hesitancy, RFP, Program, Merck & Co., Associate, London School of Hygiene & Tropical Medicine, Centers for Disease Control and Prevention, Immunization, Vaccination, VCF, Insight dialogue, Natural language processing, Tropical medicine, Health, Organization, Pharmaceutical industry, Fund, Hygiene

This round of funding for global research will focus on harnessing the power of social media to increase vaccination confidence and uptake with an emphasis on enhancing routine immunization and educating health care workers on addressing vaccine hesitancy.

Key Points: 
  • This round of funding for global research will focus on harnessing the power of social media to increase vaccination confidence and uptake with an emphasis on enhancing routine immunization and educating health care workers on addressing vaccine hesitancy.
  • Global Impact is publishing the Full Insights Report on the first Vaccine Confidence Fund which features findings from the grantees research and insights on potential ways to drive vaccination confidence and uptake.
  • Through these partnerships, Global Impact has raised nearly $2 billion for causes such as disaster relief and global development.
  • Global Impacts reach and services are complemented by the work of its subsidiary company, Geneva Global .

Statement from the Chief Public Health Officer of Canada on August 5, 2022

Retrieved on: 
Friday, August 5, 2022
Death, Ageing, Public health, COVID-19 vaccine, Risk, Mortality, Ventilation, Omicron, COVID, Review, Epidemiology, COVID-19, Crowding, Vaccine, SAS, Vaccination, Disease, Public Health Agency of Canada, Black fungus (COVID-19 condition), PHAC, Pharmaceutical industry

Similar to previous waves, lagging severity indicators are slower to decline, but are expected to stabilize and decline following infection rates.

Key Points: 
  • Similar to previous waves, lagging severity indicators are slower to decline, but are expected to stabilize and decline following infection rates.
  • Because the Omicron variant, including sub-lineages are immune evasive, two doses of COVID-19 vaccines offer less protection than against previous variants.
  • Over the past 30 days, preliminary estimates for some severity trends have exceeded average rates seen previously throughout the pandemic.
  • Specifically, this Public Health Agency of Canada modelling study explores what could have happened (counterfactuals modelling) without the combined effects of vaccination and public health measures to reduce COVID-19 spread and severity in Canada.

Indigenous Services Canada COVID-19 monthly update - August 2022

Retrieved on: 
Friday, August 5, 2022
Indigenous Services Canada, Food, Surge (drink), Public health, COVID-19 vaccine, First Nations, COVID-19, Indigenous self-government in Canada, MTI College, ISC, Vaccine, Transport, Health Canada, Government, PPE, Vaccination, Moderna, ICSF, Health, Organization, Pharmaceutical industry, Whaling, Indigenous

Indigenous Services Canada remains available to assist in prevention and response efforts.

Key Points: 
  • Indigenous Services Canada remains available to assist in prevention and response efforts.
  • The Government of Canada is monitoring COVID-19 throughout the country, including the newest variants of concern, B.4 and B.5.
  • Vaccines for children:On July 14, 2022, Health Canada authorized the Moderna SPIKEVAX mRNA COVID-19 vaccine for children 6 months to 5 years of age.
  • On April 7, Budget 2022 committed an additional $190.5 million to the Indigenous Community Support Fund (ICSF).

Croatia Construction Industry Report 2022 - ResearchAndMarkets.com

Retrieved on: 
Friday, August 5, 2022
Construction & Property, Other Construction & Property, Sustainable development, Carbon, Omicron, Growth, Croatian Bureau of Statistics, Investment, Construction, Sector, Government, Yoy, COVID-19, Ministry, Vaccination, Commercial, CBS, Renewable energy, Coronavirus

The "Croatia Construction Market Size, Trends and Forecasts by Sector - Commercial, Industrial, Infrastructure, Energy and Utilities, Institutional and Residential Market Analysis, 2022-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Croatia Construction Market Size, Trends and Forecasts by Sector - Commercial, Industrial, Infrastructure, Energy and Utilities, Institutional and Residential Market Analysis, 2022-2026" report has been added to ResearchAndMarkets.com's offering.
  • Following an annual growth of 4.1% in 2020, Croatia's construction industry expanded by an estimated 7.8% in 2021, supported by the government's expansionary policy measures and improvement in the civil engineering and building construction sector.
  • The publisher expects the construction industry to expand by 4.4% in real terms this year, before registering annual growth in the range of 2.2-2.4% from 2023 to 2026.
  • Historical (2017-2021) and forecast (2022-2026) valuations of the construction industry in Croatia, featuring details of key growth drivers.